206 related articles for article (PubMed ID: 16540637)
1. Signal transducers and activators of transcription 3 activation is involved in nuclear accumulation of beta-catenin in colorectal cancer.
Kawada M; Seno H; Uenoyama Y; Sawabu T; Kanda N; Fukui H; Shimahara Y; Chiba T
Cancer Res; 2006 Mar; 66(6):2913-7. PubMed ID: 16540637
[TBL] [Abstract][Full Text] [Related]
2. Nuclear beta-catenin accumulation as a prognostic factor in Dukes' D human colorectal cancers.
Miyamoto S; Endoh Y; Hasebe T; Ishii G; Kodama K; Goya M; Ono M; Saitoh N; Chiba T; Ochiai A
Oncol Rep; 2004 Aug; 12(2):245-51. PubMed ID: 15254684
[TBL] [Abstract][Full Text] [Related]
3. SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of beta-catenin and its nuclear signaling.
Coluccia AM; Benati D; Dekhil H; De Filippo A; Lan C; Gambacorti-Passerini C
Cancer Res; 2006 Feb; 66(4):2279-86. PubMed ID: 16489032
[TBL] [Abstract][Full Text] [Related]
4. Serum response factor enhances liver metastasis of colorectal carcinoma via alteration of the E-cadherin/beta-catenin complex.
Choi HN; Kim KR; Lee JH; Park HS; Jang KY; Chung MJ; Hwang SE; Yu HC; Moon WS
Oncol Rep; 2009 Jan; 21(1):57-63. PubMed ID: 19082443
[TBL] [Abstract][Full Text] [Related]
5. Nuclear beta-catenin expression at the invasive front and in the vessels predicts liver metastasis in colorectal carcinoma.
Suzuki H; Masuda N; Shimura T; Araki K; Kobayashi T; Tsutsumi S; Asao T; Kuwano H
Anticancer Res; 2008; 28(3B):1821-30. PubMed ID: 18630466
[TBL] [Abstract][Full Text] [Related]
6. Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis.
Chung GG; Provost E; Kielhorn EP; Charette LA; Smith BL; Rimm DL
Clin Cancer Res; 2001 Dec; 7(12):4013-20. PubMed ID: 11751495
[TBL] [Abstract][Full Text] [Related]
7. [Relationship of Stat3 and its target gene products with malignancy in human colorectal carcinoma].
Ma XT; Wang S; Ye YJ; Du RY; Cui ZR
Ai Zheng; 2003 Nov; 22(11):1135-9. PubMed ID: 14613639
[TBL] [Abstract][Full Text] [Related]
8. Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome.
Pancione M; Forte N; Sabatino L; Tomaselli E; Parente D; Febbraro A; Colantuoni V
Hum Pathol; 2009 May; 40(5):714-25. PubMed ID: 19121846
[TBL] [Abstract][Full Text] [Related]
9. [Correlation between Stat3 signal transduction pathway and expression of cyclooxygenase-2 in colorectal cancer cells].
Zhang H; Wang S; Zhang YC; Ye YJ; Cui ZR; Fang WG
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(41):2899-904. PubMed ID: 16324362
[TBL] [Abstract][Full Text] [Related]
10. Activation of STAT3 is a marker of poor prognosis in human colorectal cancer.
Kusaba T; Nakayama T; Yamazumi K; Yakata Y; Yoshizaki A; Inoue K; Nagayasu T; Sekine I
Oncol Rep; 2006 Jun; 15(6):1445-51. PubMed ID: 16685378
[TBL] [Abstract][Full Text] [Related]
11. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer.
Duan Z; Foster R; Bell DA; Mahoney J; Wolak K; Vaidya A; Hampel C; Lee H; Seiden MV
Clin Cancer Res; 2006 Sep; 12(17):5055-63. PubMed ID: 16951221
[TBL] [Abstract][Full Text] [Related]
12. Altered distribution of beta-catenin and prognostic roles in colorectal carcinogenesis.
Chen S; Liu J; Li G; Mo F; Xu X; Zhang T; Zhang X; Li J; Han X; Sun Y
Scand J Gastroenterol; 2008; 43(4):456-64. PubMed ID: 18365911
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Stat3 increases doxorubicin sensitivity in a human metastatic breast cancer cell line.
Gariboldi MB; Ravizza R; Molteni R; Osella D; Gabano E; Monti E
Cancer Lett; 2007 Dec; 258(2):181-8. PubMed ID: 17920763
[TBL] [Abstract][Full Text] [Related]
14. beta-Catenin/TCF pathway upregulates STAT3 expression in human esophageal squamous cell carcinoma.
Yan S; Zhou C; Zhang W; Zhang G; Zhao X; Yang S; Wang Y; Lu N; Zhu H; Xu N
Cancer Lett; 2008 Nov; 271(1):85-97. PubMed ID: 18602747
[TBL] [Abstract][Full Text] [Related]
15. Beta-catenin expression in relation to genetic instability and prognosis in colorectal cancer.
MÃ¥rtensson A; Oberg A; Jung A; Cederquist K; Stenling R; Palmqvist R
Oncol Rep; 2007 Feb; 17(2):447-52. PubMed ID: 17203186
[TBL] [Abstract][Full Text] [Related]
16. Efficient killing of SW480 colon carcinoma cells by a signal transducer and activator of transcription (STAT) 3 hairpin decoy oligodeoxynucleotide--interference with interferon-gamma-STAT1-mediated killing.
Tadlaoui Hbibi A; Laguillier C; Souissi I; Lesage D; Le Coquil S; Cao A; Metelev V; Baran-Marszak F; Fagard R
FEBS J; 2009 May; 276(9):2505-15. PubMed ID: 19476491
[TBL] [Abstract][Full Text] [Related]
17. Activation of signal transducer and activator of transcription 3 in renal cell carcinoma: a study of incidence and its association with pathological features and clinical outcome.
Horiguchi A; Oya M; Shimada T; Uchida A; Marumo K; Murai M
J Urol; 2002 Aug; 168(2):762-5. PubMed ID: 12131365
[TBL] [Abstract][Full Text] [Related]
18. L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer.
Boo YJ; Park JM; Kim J; Chae YS; Min BW; Um JW; Moon HY
Ann Surg Oncol; 2007 May; 14(5):1703-11. PubMed ID: 17211730
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological significance of expression of p-c-Jun, TCF4 and beta-Catenin in colorectal tumors.
Takeda K; Kinoshita I; Shimizu Y; Ohba Y; Itoh T; Matsuno Y; Shichinohe T; Dosaka-Akita H
BMC Cancer; 2008 Nov; 8():328. PubMed ID: 18992165
[TBL] [Abstract][Full Text] [Related]
20. Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicity.
Buettner R; Huang M; Gritsko T; Karras J; Enkemann S; Mesa T; Nam S; Yu H; Jove R
Mol Cancer Res; 2007 Aug; 5(8):823-32. PubMed ID: 17699108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]